Clin2
NCT06247046Likely a fitRecruiting

Probiotic powder for IBS-D (SK08) trial

Irritable Bowel Syndrome With Diarrhea

Part of Digestive system clinical trials.

This study tests a new probiotic powder (SK08) to see if it reduces belly pain and diarrhea in people with IBS-D (irritable bowel syndrome with diarrhea). It lasts several months and involves taking the study powder twice a day.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,298 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • Must be 18 to 70 years old
  • Diagnosed with IBS with diarrhea (IBS-D) for at least 6 months, with belly pain and loose stools most days for the past 3 months
  • Had a colonoscopy in the past year (with or without small polyps removed) – and your IBS symptoms have continued since then
  • During a 2‑week run‑in period, you had loose stools at least 4 days per week and your daily belly pain score averaged at least 3 out of 10 on those days
  • No other serious health conditions (like heart, kidney, autoimmune disease, or poorly managed diabetes/thyroid), no abdominal/pelvic surgery (except simple ones), and no current or recent use of certain gut‑affecting medications

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06960369Recruiting· Phase 1
Brain stimulation and probiotics for diarrhea-predominant IBS

This trial tests whether combining a type of brain stimulation (repetitive transcranial magnetic stimulation) with a probiotic tablet can help people with diarrhea-predominant irritable bowel syndrome. It aims to improve symptoms by targeting both the brain and the gut.

Suzhou, Jiangsu
NCT06725017Not yet recruiting· Phase 2
Live bacteria powder for ulcerative colitis

This trial tests a live bacteria powder (SK08) taken by mouth for ulcerative colitis. It aims to see if the bacteria can reduce inflammation and improve symptoms. You may qualify if standard treatments haven't worked well for you.

NCT06636513Recruiting
Testing SMT04 for irritable bowel syndrome

This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.

Singapore, Singapore
NCT07475299Not yet recruiting
Gut health supplement for irritable bowel syndrome

This study tests a daily supplement containing beneficial bacteria (synbiotic) and plant extracts to improve gut health and reduce symptoms of irritable bowel syndrome (IBS), such as bloating, gas, and changes in bowel habits. It lasts about 16 weeks and involves taking the supplement and providing blood and stool samples.

Cluj-Napoca
NCT07584278Recruiting
Probiotics and Biomarkers for Irritable Bowel Syndrome

This study tests whether probiotics (beneficial bacteria) can help reduce irritable bowel syndrome (IBS) symptoms and change certain markers in your gut. You'll take a probiotic supplement for 12 weeks while researchers track how your symptoms and gut health change.

Gothenburg
NCT07872514Enrolling by invitation
Personalized probiotics for irritable bowel syndrome

This study tests whether a probiotic treatment designed specifically for you can help ease your irritable bowel syndrome (IBS) symptoms. If you make it into the study, you'll get a treatment plan tailored to your gut and your symptoms.

Hamilton, Ontario

Hear when a new Irritable Bowel Syndrome - Diarrhoea trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.